QIM
LUMO

Quantitative Investment Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Quantitative Investment Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,600
Closed -$635K – 873
2017
Q2 		$635K Buy
+9,600
New +$1.19M 0.01% 613
2017
Q1 		– Sell
-1,867
Closed -$172K – 950
2016
Q4 		$172K Sell
1,867
-1,189
-39% -$134K ﹤0.01% 756
2016
Q3 		$413K Sell
3,056
-3,833
-56% -$381K 0.01% 563
2016
Q2 		$698K Buy
6,889
+4,500
+188% +$558K 0.03% 493
2016
Q1 		$391K Buy
+2,389
New +$484K 0.02% 585

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Quantitative Investment Management's LUMO Position: Q3 2017 in Review

Quantitative Investment Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2017, closing a stake of 9,600 shares — an estimated $635K sold.

Quantitative Investment Management first reported a position in LUMO in Q1 2016 and held it in 5 quarters. The position peaked at $698K in Q2 2016. 126 funds tracked by Wall St. Rank hold LUMO as of Q3 2017.

  • Quantitative Investment Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Quantitative Investment Management sold 9,600 Lumos Pharma, Inc. Common Stock shares in Q3 2017, an estimated $635K.
  • Quantitative Investment Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2016 and held it in 5 quarters.
  • Quantitative Investment Management's Lumos Pharma, Inc. Common Stock position peaked at $698K in Q2 2016.
  • 126 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2017.

Based on Quantitative Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.